Golumbeski George
SEC insider (Form 3/4/5 filer). CIK 0001586660. Director at Acumen Pharmaceuticals, Inc. (ABOS) and 3 other issuers. 12 reported Form 4/5 transactions since Sep 2024; latest on Jun 3, 2026. Located in AUSTIN, TX.
Companies Golumbeski George has filed insider reports for
- Acumen Pharmaceuticals, Inc. (ABOS): Director
- Shattuck Labs, Inc. (STTK): Director
- Mural Oncology plc (MURA): Director
- Sage Therapeutics, Inc. (SAGE): Director
Golumbeski George
CIK: 0001586660
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Jun 3, 2026ABOS
Acumen Pharmaceuticals, Inc.
AwardDirect35.5K shares- - May 29, 2026STTK
Shattuck Labs, Inc.
AwardDirectStock Option (Right to Buy)
81K shares- - Dec 5, 2025MURA
Mural Oncology plc
DispositionDirectStock Option (right to buy)
15.3K shares- - Dec 5, 2025MURA
Mural Oncology plc
DispositionDirectStock Option (right to buy)
8.6K shares- - Nov 6, 2025ABOS
Acumen Pharmaceuticals, Inc.
AwardDirectStock Option (right to buy)
50K shares- - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
21.5K shares- - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
DispositionDirectStock Option (Right to Buy)
13.6K shares- - Jul 31, 2025SAGE
Sage Therapeutics, Inc.
Tender OfferDirect8K shares- - Jul 14, 2025STTK
Shattuck Labs, Inc.
AwardDirectStock Option (Right to Buy)
33.2K shares- - Jun 11, 2025SAGE
Sage Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
21.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 3, 2026 |  ABOS Acumen Pharmaceuticals, Inc. | Award | 35,500 | - | $0 | Direct |
| May 29, 2026 |  STTK Shattuck Labs, Inc. | Award Stock Option (Right to Buy) | 81,000 | - | - | Direct |
| Dec 5, 2025 |  MURA Mural Oncology plc | Disposition Stock Option (right to buy) | 15,334 | - | - | Direct |
| Dec 5, 2025 | MURA Mural Oncology plc | Disposition Stock Option (right to buy) | 8,637 | - | - | Direct |
| Nov 6, 2025 | ABOS Acumen Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 50,000 | - | - | Direct |
| Jul 31, 2025 |  SAGE Sage Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 21,500 | - | - | Direct |
| Jul 31, 2025 | SAGE Sage Therapeutics, Inc. | Disposition Stock Option (Right to Buy) | 13,593 | - | - | Direct |
| Jul 31, 2025 | SAGE Sage Therapeutics, Inc. | Tender Offer | 8,000 | - | - | Direct |
| Jul 14, 2025 | STTK Shattuck Labs, Inc. | Award Stock Option (Right to Buy) | 33,150 | - | - | Direct |
| Jun 11, 2025 | SAGE Sage Therapeutics, Inc. | Award Stock Option (Right to Buy) | 21,500 | - | - | Direct |
1-10 of 12 transactions